Final Program
Registration Information
Preliminary Program
Visa Letter
Itinerary Builder

Abstracts
The submitter is closed for new submissions.  We e-mailed notifications of acceptance on March 20. 

Hotel Accommodations
The AHA has reserved rooms for conference participants and their guests at the Denver Marriott City Center at special reduced rates.  Rooms will be available on a first-come, first-served basis until all are filled or until the cut-off date of April 4, 2006.  To take advantage of these rates, call (303) 297-1300 or (800) 228-9290 and ask for Reservations.  Please inform the hotel that you are participating in the American Heart Association’s 7^th Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology. You may also book your room online vy visiting the Marriott's online reservation page.

Rates are $129 single occupancy and $139 double occupancy and are subject to state, local and occupancy taxes.  Hotel check-in time is 3 p.m.; check-out time is noon.

The conference will take place at the Denver Marriott CityCenter. The hotel is located at 170 California Street, Denver, CO  80202.

Awards
Jeffrey M. Hoeg Arteriosclerosis, Thrombosis and Vascular Biology Award for Basic Science and Clinical Research
Irvine H. Page Young Investigator Research Award
Kenneth M. Brinkhous Young Investigator Prize in Thrombosis
Junior Investigator Award for Women 
New Investigator Travel Awards

Program Description
This two-and-one-half day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology and the Council on Nutrition, Physical Activity and Metabolism.  The meeting will focus on new developing research opportunities in arteriosclerosis, thrombosis and vascular biology.  The conference includes special lectures, discussions, and oral and poster presentations.  The meeting format provides opportunities for intense interaction among the participants during the sessions and breaks.

The meeting brings together diverse disciplines within the arteriosclerosis, thrombosis and vascular biology research communities to allow investigators to explore areas of cross-disciplinary interest.  The program encourages cross-fertilization by examining new and emerging areas in lipids and lipoproteins, arteriosclerosis, thrombosis and vascular biology in an informal setting.  Sessions planned by each of the representative areas, i.e., arteriosclerosis, thrombosis, vascular biology, and nutrition/physical activity/metabolism, will provide an opportunity for oral presentations of abstracts.  We hope that the interdisciplinary approach will serve as a template for future meetings that encompass a broad view of arteriosclerosis, thrombosis and vascular biology.

Who Should Attend
Clinicians, researchers, nurses, and other health professionals interested in lipids and lipoproteins, arteriosclerosis, thrombosis, and vascular biology can benefit from attending the abstract presentations, discussions and lectures from prestigious faculty covering a wide range of topics.

Learning Objectives
At the conclusion of the conference, participants should be able to:

1. Discuss the complex molecular and cellular events involved in the artery wall that are a prerequisite for an improved understanding of the pathogenesis of cardiovascular disease and for designing specific and improved interventions to prevent clinical disease.
2. Integrate an understanding of cardiovascular disease at the fundamental level with emphasis on nuclear hormone receptors, genetics of atherosclerosis, cellular lipid trafficking, cell-cell and cell-matrix interactions, platelet biology, thrombosis and thrombolysis, control of coagulation factors, angiogenesis, vascular development, stem cells, lipid rafts, fatty acid metabolism, obesity and diabetes, nutrition and physical activity, lipoprotein metabolism, leukocyte biology, and cell signaling.
3. Recognize various mechanisms involved in thrombosis, vascular biology and atherosclerosis.
4. Develop new insights that will lead to novel and effective interventions to prevent cardiovascular disease.

Continuing Medical Education

The American Heart Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Heart Association designates this educational activity for a maximum of 20.75 category 1 credits toward the AMA Physician’s Recognition Award.  Each physician should claim only those credits that he/she actually spent in the activity.

All faculty participating in CME/CE activities sponsored by The American Heart Association will disclose to the audience (1) significant financial relationships with the manufacturer(s) of products from the commercial supporter(s) and /or the manufacturer(s) of products or devices discussed in their presentation, and (2) unlabeled/unapproved uses of drugs or devices discussed in their presentation.  Such disclosures will be made in writing in course presentation materials.

Please visit our Professional Education Center to claim your CME or view other course offerings.
www.professionaleducationcenter.americanheart.org

Abstract Presentation Guidelines
Oral Guidelines
*Templates for Disclosure Slides (Oral Abstracts)
Poster Guidelines

KinMet Symposium
Satellite Symposium on Kinetics and Kinetic Modeling of Lipoprotein, Lipid, and Sterol Metabolism in Systems Ranging from Human Subjects to Cultured Cells

Wednesday, April 26, 2006
Noon - 6 p.m.

Denver Marriott City Center, Denver Ballroom IV

Additional information may be found at:
http://www.bioinformaticsservices.com (click on KinMet2006)

This symposia is not part of the accredited continuing education activities.

Photography Note
Please be aware that during the 7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, attendees, vendors and guests may be photographed and videotaped by AHA vendors in capturing the event.  Some of these photographs or videos may be displayed by the AHA in future publications or materials connected with the event.  If you do not want your image displayed by the AHA, please contact the AHA in writing at 7272 Greenville Avenue, Dallas, TX 75231-4596, no later than April 20.

More Information:
E-mail: scientificconferences@heart.org
Phone: (214) 570-5935 or (888) 242-2453
News Media Relations Telephone: (214) 706-1396
Sponsorship Opportunities: ellen.haynes@heart.org

Abstracts, lectures and presentations at the 7^th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology are embargoed for release at the time of presentation. Information may not be released before the scheduled presentation time.